How Webster was paid
$18.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Incentive | Other | Total |
|---|---|---|---|---|---|
| Brian WebsterPresident, Chief Executive Officer & Director | $589,098 | $17,889,000 | $359,000 | $53,632 | $18,890,730 |
| Vaseem MahboobChief Financial Officer | $427,828 | $1,648,830 | $187,000 | $59,424 | $2,323,082 |
| Traci S. UmbergerGeneral Counsel, Chief Administrative Officer & Director | $401,411 | $5,437,050 | $179,000 | $50,128 | $6,067,589 |
What changed and why
- $17.9M$17,889,000 in option awards drove CEO total compensation to $18,890,730 in 2025.
- 100%100% of target annual bonuses were paid after the Board determined performance goals were achieved.
- 50%50% was the CEO's target bonus opportunity, compared with 40% for the other NEOs.
- $760K$760,000 became the CEO's annual base salary effective March 6, 2025.
- 60%March 6, 2025 IPO options vested 60% immediately for Webster and Umberger, with the remainder vesting over two years.
- Annual RSU and performance-based RSU awards granted June 4, 2025 will be disclosed in fiscal 2026.
Other Kestra Medical Technologies proxy statements
- 2026 proxy statement
Brian Webster paid $7.5M (-60% on the year).
Filed Jul 28, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.